Search research articles
Contact Us
Filters
Showing results (901-910 of 1,034) with videos related to
Page
of 104
Sort By:
Plant Physiology
|
June 3, 2025
Shoring up the base: The development and regulation of cortical sclerenchyma in grass nodal roots
Ian W McCahill, Logayn T Abushal, Bahman Khahani, et al.
Biorxiv : the Preprint Server for Biology
|
July 9, 2024
Dual roles of histone H3 lysine-4 in antagonizing Polycomb group function and promoting target gene expression
Cyril S Anyetei-Anum, Mary P Leatham-Jensen, Geoffrey C Fox, et al.
Science Advances
|
November 10, 2023
<i>TWIST1</i> and <i>TSG6</i> are coordinately regulated and function as potency biomarkers in human MSCs
Ryang Hwa Lee, Siddaraju V Boregowda, Taeko Shigemoto-Kuroda, et al.
Oncogene
|
July 17, 2012
Mutant p53 drives invasion in breast tumors through up-regulation of miR-155
P M Neilsen, J E Noll, S Mattiske, et al.
Behavior Research Methods
|
December 20, 2024
The Salford Nature Environments Database (SNED): an open-access database of standardized high-quality pictures from natural environments
Robert C A Bendall, Sam Royle, James Dodds, et al.
Journal of Cell Science
|
March 26, 2013
Epigenetic modulation of the miR-200 family is associated with transition to a breast cancer stem-cell-like state
Yat-Yuen Lim, Josephine A Wright, Joanne L Attema, et al.
The Oncologist
|
December 7, 2013
Low incidence of pseudoprogression by imaging in newly diagnosed glioblastoma patients treated with cediranib in combination with chemoradiation
Marco C Pinho, Pavlina Polaskova, Jayashree Kalpathy-Cramer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 20, 2007
Phase I trial of toll-like receptor 9 agonist PF-3512676 with and following rituximab in patients with recurrent indolent and aggressive non Hodgkin's lymphoma
John P Leonard, Brian K Link, Christos Emmanouilides, et al.
Genome Research
|
May 17, 2018
Mapping and characterizing N6-methyladenine in eukaryotic genomes using single-molecule real-time sequencing
Shijia Zhu, John Beaulaurier, Gintaras Deikus, et al.
ESMO Open
|
April 11, 2025
Afatinib in patients with solid tumors with neuregulin 1 (NRG1) fusions: a case series from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
J Rodon, M Rothe, P K Mangat, et al.
Page
of 104
Search research articles
Search
Showing results (901-910 of 1,034) with videos related to
Sort By:
Page
of 104
Plant Physiology
|
June 3, 2025
Shoring up the base: The development and regulation of cortical sclerenchyma in grass nodal roots
Ian W McCahill, Logayn T Abushal, Bahman Khahani, et al.
Biorxiv : the Preprint Server for Biology
|
July 9, 2024
Dual roles of histone H3 lysine-4 in antagonizing Polycomb group function and promoting target gene expression
Cyril S Anyetei-Anum, Mary P Leatham-Jensen, Geoffrey C Fox, et al.
Science Advances
|
November 10, 2023
<i>TWIST1</i> and <i>TSG6</i> are coordinately regulated and function as potency biomarkers in human MSCs
Ryang Hwa Lee, Siddaraju V Boregowda, Taeko Shigemoto-Kuroda, et al.
Oncogene
|
July 17, 2012
Mutant p53 drives invasion in breast tumors through up-regulation of miR-155
P M Neilsen, J E Noll, S Mattiske, et al.
Behavior Research Methods
|
December 20, 2024
The Salford Nature Environments Database (SNED): an open-access database of standardized high-quality pictures from natural environments
Robert C A Bendall, Sam Royle, James Dodds, et al.
Journal of Cell Science
|
March 26, 2013
Epigenetic modulation of the miR-200 family is associated with transition to a breast cancer stem-cell-like state
Yat-Yuen Lim, Josephine A Wright, Joanne L Attema, et al.
The Oncologist
|
December 7, 2013
Low incidence of pseudoprogression by imaging in newly diagnosed glioblastoma patients treated with cediranib in combination with chemoradiation
Marco C Pinho, Pavlina Polaskova, Jayashree Kalpathy-Cramer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 20, 2007
Phase I trial of toll-like receptor 9 agonist PF-3512676 with and following rituximab in patients with recurrent indolent and aggressive non Hodgkin's lymphoma
John P Leonard, Brian K Link, Christos Emmanouilides, et al.
Genome Research
|
May 17, 2018
Mapping and characterizing N6-methyladenine in eukaryotic genomes using single-molecule real-time sequencing
Shijia Zhu, John Beaulaurier, Gintaras Deikus, et al.
ESMO Open
|
April 11, 2025
Afatinib in patients with solid tumors with neuregulin 1 (NRG1) fusions: a case series from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
J Rodon, M Rothe, P K Mangat, et al.
Page
of 104